Concepedia

Preladenant in patients with Parkinson's disease and motor fluctuations: a phase 2, double-blind, randomised trial

Robert A. Hauser, Marc Cantillon, Emmanuelle Pourcher, Federico Micheli, Vincent Mok, Marco Onofrj, Susan Huyck, Kenneth Wolski

The Lancet Neurology · 2011 · 195 citations · 14 references

DOI

Concepts

References

14

Striatal Restricted Adenosine A<sub>2</sub> Receptor (RDC8) Is Expressed by Enkephalin but Not by Substance P Neurons: An In Situ Hybridization Histochemistry Study

Serge N. Schiffmann, O. E. Jacobs, Jean‐Jacques Vanderhaeghen · Journal of Neurochemistry · 1991 · 531 citations

, , +15

Adenosine A <sub>2A</sub> receptor antagonist istradefylline (KW‐6002) reduces “off” time in Parkinson's disease: A double‐blind, randomized, multicenter clinical trial (6002‐US‐005)

Peter A. LeWitt, Mark Guttman, James W. Tetrud et al. · Annals of Neurology · 2008 · 350 citations

, , +13

Randomized trial of the adenosine A <sub>2A</sub> receptor antagonist istradefylline in advanced PD

Robert A. Hauser, Jean Hubble, Daniel D. Truong · Neurology · 2003 · 297 citations

, , +16

Utility of an objective dyskinesia rating scale for Parkinson's disease: Inter‐ and intrarater reliability assessment

Christopher G. Goetz, Glenn T. Stebbins, Heidi Shale et al. · Movement Disorders · 1994 · 276 citations

, , +10

Ultrastructural localization of adenosine A2A receptors suggests multiple cellular sites for modulation of GABAergic neurons in rat striatum

Barbara D. Hettinger, Amy Lee, Joel Linden et al. · The Journal of Comparative Neurology · 2001 · 243 citations

, , +17